The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
Xuan Zhang(Huazhong University of Science and Technology), Qiang Zhang(Peking University), Xin Yao(Peking University), Yi‐Quan Tang(China Pharmaceutical University), Ting Zhong(Shanghai Jiao Tong University), Yang Zhao(Guangxi Medical University), Chao Wang(Shanghai Jiao Tong University), Wei Ren(Nanjing Drum Tower Hospital), Yang Guo(Peking University), Wei-Qiang Zhang(Peking University), Shuang Zhang(Peking University), Xin Wang(Peking University), Dan Huang(First Affiliated Hospital of Chengdu Medical College)
Cited by 60
Related Papers
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
Dibutyl phthalate release from polyvinyl chloride microplastics: Influence of plastic properties and environmental factors
|Water Research|2021|257
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|254